-
The vice president, who chairs the White House coronavirus task force, is the most high-profile U.S. official so far to receive the vaccine.
-
Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.
-
"Donors will no longer be asked to declare if they have had sex with another man, making the criteria for blood donation gender neutral and more inclusive," the National Health Service explains.
-
An independent federal advisory committee to the CDC recommends the Pfizer-BioNTech vaccine for people over 16. But state health leaders say distribution and funding challenges remain.
-
Army Gen. Gustave Perna told reporters that distribution of the vaccine from Pfizer and BioNTech has begun, with shipment to 636 sites scheduled to begin on Monday.
-
As FDA emergency use authorization of Pfizer and Moderna vaccines nears, airlines, FedEx and UPS prepare to transport millions of vials of life saving shots.
-
A Pfizer board member says the government declined to buy more doses beyond the initial 100 million already agreed upon. Demand from other countries could complicate future purchases.
-
The vaccine produced by Pfizer and BioNTech is the first to be authorized by Canadian health officials. The decision makes Canada just the third country in the world to grant such an authorization.
-
Mass vaccinations will start less than a week after the U.K. approved the new drug. Welsh First Minister Mark Drakeford says it could start "a long path back to normality."
-
A British regulatory agency approved the Pfizer/BioNTech vaccine Wednesday. It could be dispersed within days to the neediest people, government officials said.